| abstract |
The present application provides an RNA plasmid delivery system for the treatment of lung cancer. The system includes a plasmid carrying an RNA fragment capable of treating lung cancer, the plasmid is capable of enriching in the organ tissue of a host, and endogenously spontaneously forms in the host organ tissue an RNA fragment containing the RNA fragment A composite structure capable of delivering the RNA fragments into the lungs for the treatment of lung cancer. The safety and reliability of the RNA delivery system for the treatment of lung cancer provided by the present application have been fully verified, the drugability is very good, the versatility is strong, and it has excellent economic benefits and application prospects. |